UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Jun

    04

    Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs

    Read More Share:linkedin| twitter| email| facebook

    Jun

    02

    Partnering with Patient Communities to Advance HS Awareness and Care

    Read More Share:linkedin| twitter| email| facebook

    May

    30

    Recognizing Myasthenia Gravis Month – The Importance of Addressing Unmet Patient Needs

    At UCB, we work 365-days-a-year to find new ways to deliver solutions, peace of mind, and opportunities to people living with severe diseases because everyone deserves to live the best life they can.

    Read More Share:linkedin| twitter| email| facebook

    Apr

    22

    Earth Day 2025: Advancing Our Commitment to a Healthier Planet

    Read More Share:linkedin| twitter| email| facebook

    Apr

    03

    UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025

    Read More Share:linkedin| twitter| email| facebook

    Mar

    31

    The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American Academy of Neurology 2025

    Read More Share:linkedin| twitter| email| facebook

    Mar

    28

    Join UCB at the MGFA National Patient Conference and Visit Our Experience Room

    Read More Share:linkedin| twitter| email| facebook

    Mar

    27

    UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star

    Read More Share:linkedin| twitter| email| facebook

    Mar

    19

    New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference

    Read More Share:linkedin| twitter| email| facebook

    Mar

    12

    Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome

    Read More Share:linkedin| twitter| email| facebook

    © 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
    USPR-CORP-0115-00003(2)

    OSZAR »